Publication Name	World Journal of Clinical Cases
Manuscript ID	97677
Country	China

Received	2024-06-05 05:10
Peer-Review Started	2024-06-05 05:10
To Make the First Decision
Return for Revision	2024-09-26 10:01
Revised	2024-10-09 19:14
Second Decision	2024-11-25 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-25 06:52
Articles in Press	2024-11-25 06:52
Publication Fee Transferred	2024-10-19 10:04
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-12-02 00:48
Publish the Manuscript Online	2024-12-04 08:24

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Case Report
Article Title	Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Yuan-Jing Jiang, Lu Wu, Xiao Yang, Yu Pu, Bing-Jie Ning, Na Peng and Xiao-Ju Zhu
Funding Agency and Grant Number
Corresponding Author	Xiao-Ju Zhu, MSc, RN, Associate Chief Nurse, Chief Nurse, Teacher, Cancer Center, Daping Hospital, Army Medical University, No. 10 Changjiang Zhilu, Yuzhong District, Chongqing, Chongqing 400042, China. 277264923@qq.com
Key Words	Camrelizumab; Anti-programmed cell death protein-1 blockade; Skin-related adverse events; Immune-related dermatitis; Case report
Core Tip	The use of immune checkpoint inhibitors has complemented and enriched the treatment options other than radiation and chemotherapy, and has been recognized by the tumor population. The growing availability and clinical use of immune checkpoint inhibitors have raised significant clinical concerns regarding their safety. Timely identification and diagnosis, coupled with multidisciplinary consultation and the prompt administration of immunosuppressants, can effectively address severe immune-related adverse reactions. This report outlines the treatment course and outcome of a case featuring immune-related cutaneous adverse reactions, hope to provide different perspectives for immunotherapy and care of tumors to get the attention of peers and promote the development of related technologies.
Publish Date	2024-12-04 08:24
Citation	<p>Jiang YJ, Wu L, Yang X, Pu Y, Ning BJ, Peng N, Zhu XJ. Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report. <i>World J Clin Cases</i> 2025; 13(8): 97677</p>
URL	https://www.wjgnet.com/2307-8960/full/v13/i8/97677.htm
DOI	https://dx.doi.org/10.12998/wjcc.v13.i8.97677

Full Article (PDF)	WJCC-13-97677-with-cover.pdf
CARE Checklist–2016	97677-CARE-Checklist-2016.pdf
Manuscript File	97677_Auto_Edited_100219.docx
Answering Reviewers	97677-answering-reviewers.pdf
Audio Core Tip	97677-audio.m4a
Conflict-of-Interest Disclosure Form	97677-conflict-of-interest-statement.pdf
Copyright License Agreement	97677-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	97677-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	97677-non-native-speakers.pdf
Peer-review Report	97677-peer-reviews.pdf
Scientific Misconduct Check	97677-scientific-misconduct-check.png
Scientific Editor Work List	97677-scientific-editor-work-list.pdf
CrossCheck Report	97677-crosscheck-report.pdf